Tumors of the endolymphatic sac in von Hippel-Lindau disease

New England Journal of Medicine

Volumn 350, Issue 24, 2004, Pages 2481-2486

  Lonser, Russell R ^a   Kim, H Jeffrey ^b   Butman, John A ^c   Vortmeyer, Alexander O ^a   Choo, Daniel I ^d   Oldfield, Edward H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; ENDOLYMPHATIC SAC; ENDOLYMPHATIC SAC TUNMOR; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL BONE; TREATMENT OUTCOME; VON HIPPEL LINDAU DISEASE; BLEEDING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; EAR TUMOR; FATALITY; GENETICS; HEARING DISORDER; INNER EAR DISEASE; MUTATION; PATHOLOGY; RADIOGRAPHY; TINNITUS; VERTIGO;

ADULT; DIAGNOSTIC ERRORS; EAR NEOPLASMS; ENDOLYMPHATIC SAC; FATAL OUTCOME; FEMALE; GERM-LINE MUTATION; HEARING DISORDERS; HEMORRHAGE; HIPPEL-LINDAU DISEASE; HUMANS; LABYRINTH DISEASES; MAGNETIC RESONANCE IMAGING; MALE; TEMPORAL BONE; TINNITUS; TOMOGRAPHY, X-RAY COMPUTED; VERTIGO;

EID: 2942527104     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa040666     Document Type: Article

References (17)

1. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998;12:417-23.
2. Pack SD, Zhuang Z. Fluorescence in situ hybridization. In: Powell SM, ed. Colorectal cancer: methods and protocols. Totowa, N.J.: Humana Press, 2001:35-50.
3. Latif F, Toty K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
4. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991;337:1052-4.
5. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 2003;361:2059-67.
6. Brandt R. Aur erage der angiomatosis retinae. Von Graefes Arch Opthalmol 1921;106:127-36.
7. Lindau A. Studien über Kleinhirncysten: Bau, Pathogenese und Beziehungen zur Angiomatosis Retinæ. Acta Path Microbiol Scand Suppl 1926;1:1-128.
8. Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997;277:1461-6.
9. Choo DI, Shotland L, Mastroianni M, et al. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg 2004;100:480-7.
10. Megerian CA, Haynes DS, Poe DS, Choo DI, Keriakas TJ, Glasscock ME III. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol 2002;23:378-87.
11. Gaeta M, Blandino A, Minutoli F, Pandolfo I. Sudden unilateral deafness with endolymphatic sac adenocarcinoma: MRI. Neuroradiology 1999;41:799-801.
12. Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003;98:106-16.
13. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003;98:82-94.
14. Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases. Cancer 1989;64:2292-302.
15. Megerian CA, MeKenna MJ, Nuss RC, et al. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope 1995;105:801-8.
16. Vortmeyer AO, Choo D, Pack SD, Oldfield EH, Zhuang Z. von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst 1997;89:970-2.
17. Knudson AG Jr. Genetics of human cancer. Annu Rev Genet 1986;20:231-51.